RNS Number : 9448F
Aptamer Group PLC
24 April 2025
24 April 2025
Aptamer Group plc
("Aptamer", the "Company" or the "Group")
New Corporate Presentation and Investor Factsheet
Aptamer Group plc (AIM: APTA), the leading developer of next generation synthetic binders delivering innovation to the life science industry, is pleased to announce that it has published a new corporate presentation and investor factsheet. These materials are now available on the investor relations section of the Group's website (https://aptamergroup.com/investors/reports-and-presentations/).
The corporate presentation outlines Aptamer's strategy, operational progress and financial performance, offering a comprehensive overview of the Group's growth potential. Complementing this, the investor factsheet provides a succinct two-page summary, focused on highlighting key operational and financial metrics to support investors in their evaluation of the Group.
No new material information has been disclosed in either of these publications.
- Ends -
For further information, please contact:
Aptamer Group plc Dr Arron Tolley, Chief Executive Officer
Turner Pope Investments (TPI) Limited - Broker James Pope / Andrew Thacker
+44 (0) 20 3657 0050
Northstar Communications Limited - Investor Relations Sarah Hollins
+44 (0) 113 730 3896
About Aptamer Group
Aptamer Group is a leading developer of next generation synthetic binders delivering innovation to the life sciences industry. The Group develops Optimer® binders, advanced molecules that work like antibodies by attaching to specific targets in the body. These binders are used in medicine, diagnostic tests, and research tools, offering benefits like high stability, reliable performance, and lower costs compared to traditional antibodies.
Aptamer operates a fee-for-service business in the $210 billion market for antibody alternatives, working with all top 10 global pharmaceutical companies. It is also building valuable Optimer® assets with partners, aiming for future licensing revenue.
Founded in 2008, the Group listed on the London Stock Exchange AIM market in December 2021 and is headquartered in York, UK.
To register for news alerts by email go to https://aptamergroup.com/investors/investor-news-email-alerts/
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NRABCGDSRXDDGUX
